Center for Scientific Review; Notice of Closed Meetings, 8266-8268 [2012-3434]
Download as PDF
<![CDATA[
8266
Federal Register / Vol. 77, No. 30 / Tuesday, February 14, 2012 / Notices
bypasses the human metabolic
machinery needed to convert the drug
into its active metabolite(s).
• Decreased CNS side effects.
Development Stage: In vivo data
available (animal).
Inventors: Irving W. Wainer, Ph.D.
(NIA), Carlos A. Zarate, M.D. (NIMH),
Ruin Moaddel, Ph.D. (NIA), Michel
Bernier (NIA), Michael E. Goldberg,
M.D., Marc C. Toriman, Ph.D.
Publications:
1. Moaddel R, et al. A parallel chiralachiral liquid chromatographic
method for the determination of the
stereoisomers of ketamine and
ketamine metabolites in the plasma
and urine of patients with complex
regional pain syndrome. Talanta.
2010 Oct. 15;82(5):1892–1904.
[PMID 20875593]
2. Zarate CA Jr., et al. Relationship of
Ketamine’s Plasma Metabolites with
Response and Diagnosis, and Side
Effects in Major Depression.
Manuscript in preparation.
3. Ibrahim L, et al. Course of
Improvement in Depressive
Symptoms to a Single Intravenous
Infusion of Ketamine vs. Add-on
Riluzole: Results from a Four-Week,
Double-Blind, Placebo-Controlled
Study. Neuropsychopharmacology,
in press.
4. Zhao X, et al. Population
Pharmacokinetic Modeling of
Ketamine and Three Major
Metabolites in Patients with
Treatment-Resistant Bipolar
Depression. Br. J. Clin. Phamaco., in
press.
Intellectual Property: HHS Reference
No. E–092–2011/0—U.S. Provisional
Application No. 61/547,336 filed 14
Oct. 2011.
mstockstill on DSK4VPTVN1PROD with NOTICES
Jkt 226001
Dated: February 8, 2012.
Richard U. Rodriguez,
Director, Division of Technology Development
and Transfer, Office of Technology Transfer,
National Institutes of Health.
BILLING CODE 4140–01–P
National Institutes of Health
National Eye Institute; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended,
for the review, discussion, and
evaluation of individual intramural
PO 00000
Frm 00054
Fmt 4703
programs and projects conducted by the
National Eye Institute, including
consideration of personnel
qualifications and performances, and
the competence of individual
investigators, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors, National Eye Institute.
Date: March 4–5, 2012.
Time: 7:00 PM to 5:00 PM.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Bethesda, MD
20892.
Contact Person: Sheldon S. Miller, Ph.D.,
Scientific Director, National Institutes of
Health, National Eye Institute, Bethesda, MD
20892, (301) 451–6763.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page:
www.nei.nih.gov, where an agenda and any
additional information will be posted when
available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.867, Vision Research,
National Institutes of Health, HHS)
Dated: February 8, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–3432 Filed 2–13–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Licensing Contact: Jaime M. Greene,
M.S.; 301–435–5559;
greenejaime@mail.nih.gov.
Collaborative Research Opportunity:
The National Institute on Aging,
Laboratory of Clinical Investigation,
Bioanalytical Chemistry and Drug
Discovery Section, is seeking statements
of capability or interest from parties
interested in collaborative research to
further develop, evaluate or
commercialize this technology. For
collaboration opportunities, please
contact Nicole Guyton, Ph.D. at
darackn@mail.nih.gov.
21:57 Feb 13, 2012
Description of Technology: Nucleic
acid based vaccines are attractive
alternatives to conventional vaccines for
a number of reasons. One of the issues
with nucleic acid based vaccines is the
poor immunogenicity in humans. The
subject technology is a method for
eliciting improved immune responses
with DNA based vaccines. The method
involves co-administration of a nucleic
acid vaccine with a protein vaccine for
the same antigen of interest that is
encoded by the DNA vaccine in a primeboost protocol. This methodology
increased the immune responses in a
SIV macaque model to examine DNA
based vaccines of HIV and vaccine
protocols. The methodology can
potentially be applied to other disease
indications to elicit greater immune
responses.
Potential Commercial Applications:
Improve immunogenicity of nucleic
acid based vaccines.
Competitive Advantages: The
methodology increases the immune
response of DNA based vaccines.
Development Stage:
• Early-stage
• Pre-clinical
• In vitro data available
• In vivo data available (animal)
Intellectual Property: HHS Reference
No. E–239–2009/0—International PCT
Application No. PCT/US2011/026325
filed 25 Feb. 2011.
Licensing Contact: Kevin W. Chang,
Ph.D.; 301–435–5018;
changke@mail.nih.gov.
[FR Doc. 2012–3412 Filed 2–13–12; 8:45 am]
Related Technologies: HHS Reference
No. E–174–2006/0—
• U.S. Patent Application No. 11/
688,603 filed 20 Mar. 2007
• Related international applications
VerDate Mar<15>2010
Improved DNA-Protein Vaccination
Protocols
Sfmt 4703
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
E:\FR\FM\14FEN1.SGM
14FEN1
Federal Register / Vol. 77, No. 30 / Tuesday, February 14, 2012 / Notices
mstockstill on DSK4VPTVN1PROD with NOTICES
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Member
Continuous Receipt.
Date: February 29, 2012.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Michael M. Sveda, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2204,
MSC 7890, Bethesda, MD 20892, 301–435–
3565, svedam@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Fellowship:
Surgical Sciences, Biomedical Imaging and
Bioengineering.
Date: March 7, 2012.
Time: 12 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Weihua Luo, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5114,
MSC 7854, Bethesda, MD 20892, 301–435–
1170, luow@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Xenopus
Genetics.
Date: March 8, 2012.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institutes of Health, 6701 Rockledge
Drive, Bethesda, MD 20892, (Virtual
Meeting).
Contact Person: Richard Panniers, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2212,
MSC 7890, Bethesda, MD 20892, (301) 435–
1741, pannierr@csr.nih.gov.
Name of Committee: Center for Scientific
Review. Special Emphasis Panel Member
Conflict: Epidemiology and Genetics of
Chronic Diseases.
Date: March 8, 2012.
Time: 2 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Fungai Chanetsa, MPH,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3135,
MSC 7770, Bethesda, MD 20892, 301–408–
9436, fungai.chanetsa@nih.hhs.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Fellowships:
Behavioral Neuroscience.
Date: March 12–13, 2012.
Time: 8 a.m. to 5 p.m.
VerDate Mar<15>2010
21:57 Feb 13, 2012
Jkt 226001
Agenda: To review and evaluate grant
applications.
Place: Hotel Palomar, 2121 P Street, NW,
Washington, DC 20037.
Contact Person: Kristin Kramer, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5205,
MSC 7846, Bethesda, MD 20892, (301) 437–
0911, kramerkm@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Small
Business: Nephrology.
Date: March 12–13, 2012.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Atul Sahai, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2188,
MSC 7818, Bethesda, MD 20892, 301–435–
1198, sahaia@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Small
Business: Clinical Neurophysiology, Devices,
Neuroprosthetics, and Biosensors.
Date: March 12–13, 2012.
Time: 8 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications
Place: Hotel Nikko San Francisco, 222
Mason Street, San Francisco, CA 94102.
Contact Person: Keith Crutcher, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5207,
MSC 7846, Bethesda, MD 20892, 301–435–
1278, crutcherka@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Small
Business: Cancer Drug Developments and
Therapeutics.
Date: March 12–13, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance DC Dupont Circle
Hotel, 1143 New Hampshire Avenue NW.,
Washington, DC 20037.
Contact Person: Lilia Topol, Ph.D.
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6192,
MSC 7804, Bethesda, MD 20892, 301–451–
0131, ltopol@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Small
Business: Biochemistry, Biophysics, and
Drug Discovery.
Date: March 12, 2012.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Bethesda,
(Formerly Holiday Inn Select), 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Sergei Ruvinov, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4158,
MSC 7806, Bethesda, MD 20892, 301–435–
1180, ruvinser@csr.nih.gov.
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
8267
Name of Committee: Center for Scientific
Review Special Emphasis Panel Biological
Chemistry and Macromolecular Biophysics
B.
Date: March 12–13, 2012.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: William A. Greenberg,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4168,
MSC 7806, Bethesda, MD 20892, (301) 435–
1726, greenbergwa@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Epilepsy:
Imaging, Surgery and Sleep Disorders.
Date: March 12–13, 2012.
Time: 10 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Suzan Nadi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5217B,
MSC 7846, Bethesda, MD 20892, 301–435–
1259, nadis@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Fellowships:
Risk, Health and Healthcare.
Date: March 13–14, 2012.
Time: 8 a.m. to 5 p.m..
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda Downtown,
7335 Wisconsin Avenue, Bethesda, MD
20814.
Contact Person: Karin F Helmers, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3166,
MSC 7770, Bethesda, MD 20892, 301–254–
9975, helmersk@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel PAR–09–220
and PAR–09–221: Innovations in Biomedical
Computational Science and Technology
Initiative.
Date: March 13, 2012.
Time: 3 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Nikko San Francisco, 222
Mason Street, San Francisco, CA 94102.
Contact Person: Keith Crutcher, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5207,
MSC 7846, Bethesda, MD 20892, 301–435–
1278, crutcherka@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
E:\FR\FM\14FEN1.SGM
14FEN1
8268
Federal Register / Vol. 77, No. 30 / Tuesday, February 14, 2012 / Notices
Dated: February 7, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Notice is hereby given of a change in
the meeting of the National Cancer
Advisory Board, February 27, 2012, 6:30
PM to February 29, 2012, 12:00 PM,
National Institutes of Health, Building
31, 31 Center Drive, 10, Bethesda, MD
20892 which was published in the
Federal Register on January 18, 2012, 77
FR 2557–2558.
This notice is being amended to add
the NCAB Subcommittee on Clinical
Investigations meeting on February 27,
2012, 5 p.m. to 6:30 p.m. at the Hyatt
Regency Bethesda Hotel, One Metro
Center, Bethesda, MD 20814. The NCAB
Ad Hoc Subcommittee on Global Cancer
Research will still convene on February
27, 2012, 6:30 p.m. to 8 p.m. The
National Cancer Advisory Board
meeting has been changed to February
28, 2012 from 9 a.m. to 5 p.m., instead
of February 28–29, 2012. The meeting is
partially closed to the public.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Clinical Trial SEP.
Date: March 2, 2012.
Time: 6 p.m. to 7:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Monaco, 700 F Street NW.,
Washington, DC 20001.
Contact Person: Shanta Rajaram, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research,
NINDS/NIH/DHHS/Neuroscience Center,
6001 Executive Blvd., Suite 3208, MSC 9529,
Bethesda, MD 20892, 301–435–6033,
Rajarams@mail.nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; K99R00 Conflict Review.
Date: March 6, 2012.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Palomar, 2121 F Street NW.,
Washington, DC 20037.
Contact Person: JoAnn McConnell, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research,
NINDS/NIH/DHHS/Neuroscience Center,
6001 Executive Blvd., Suite 3208, MSC 9529,
Bethesda, MD 20892, 301–496–5324,
McConnej@ninds.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel; NIDCR U01 application
Review.
Date: March 7, 2012.
Time: 12:30 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Democracy Blvd., Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Jayalakshmi Raman, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute of Dental and
Craniofacial Research, One Democracy Plaza
Room 670, Bethesda, MD 20892–4878, 301–
594–2904, ramanj@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
Dated: February 10, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
Dated: February 7, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–3430 Filed 2–13–12; 8:45 a.m.]
[FR Doc. 2012–3438 Filed 2–13–12; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Institute of Neurological
Disorders and Stroke Notice of Closed
Meetings
National Institute of Dental &
Craniofacial Research; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
[FR Doc. 2012–3434 Filed 2–13–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
mstockstill on DSK4VPTVN1PROD with NOTICES
National Cancer Institute; Amended
Notice of Meeting
VerDate Mar<15>2010
21:57 Feb 13, 2012
Jkt 226001
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
Dated: February 8, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–3449 Filed 2–13–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Closed Meetings
Name of Committee: Center for Inherited
Disease Research Access Committee.
Date: March 8, 2012.
Time: 11:30 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, 5635 Fisher’s Lane, Room 4076,
Rockville, MD 20892, (Telephone Conference
Call).
Contact Person: Camilla E. Day, Ph.D.,
Scientific Review Officer, CIDR, National
Human Genome Research Institute, National
Institutes of Health, 5635 Fishers Lane, Suite
E:\FR\FM\14FEN1.SGM
14FEN1
]]>Agencies
[Federal Register Volume 77, Number 30 (Tuesday, February 14, 2012)]
[Notices]
[Pages 8266-8268]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-3434]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which
[[Page 8267]]
would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel Member Continuous Receipt.
Date: February 29, 2012.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Michael M. Sveda, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2204, MSC 7890, Bethesda, MD
20892, 301-435-3565, svedam@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel Fellowship: Surgical Sciences, Biomedical Imaging and
Bioengineering.
Date: March 7, 2012.
Time: 12 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Weihua Luo, MD, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5114, MSC 7854, Bethesda, MD
20892, 301-435-1170, luow@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel Xenopus Genetics.
Date: March 8, 2012.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Richard Panniers, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2212, MSC 7890, Bethesda, MD
20892, (301) 435-1741, pannierr@csr.nih.gov.
Name of Committee: Center for Scientific Review. Special
Emphasis Panel Member Conflict: Epidemiology and Genetics of Chronic
Diseases.
Date: March 8, 2012.
Time: 2 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Fungai Chanetsa, MPH, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3135, MSC 7770, Bethesda, MD
20892, 301-408-9436, fungai.chanetsa@nih.hhs.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel Fellowships: Behavioral Neuroscience.
Date: March 12-13, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hotel Palomar, 2121 P Street, NW, Washington, DC 20037.
Contact Person: Kristin Kramer, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5205, MSC 7846, Bethesda, MD
20892, (301) 437-0911, kramerkm@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel Small Business: Nephrology.
Date: March 12-13, 2012.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Atul Sahai, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 2188, MSC 7818, Bethesda, MD 20892, 301-435-
1198, sahaia@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Small Business: Clinical Neurophysiology, Devices,
Neuroprosthetics, and Biosensors.
Date: March 12-13, 2012.
Time: 8 a.m. to 3 p.m.
Agenda: To review and evaluate grant applications
Place: Hotel Nikko San Francisco, 222 Mason Street, San
Francisco, CA 94102.
Contact Person: Keith Crutcher, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5207, MSC 7846, Bethesda, MD
20892, 301-435-1278, crutcherka@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Small Business: Cancer Drug Developments and Therapeutics.
Date: March 12-13, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Renaissance DC Dupont Circle Hotel, 1143 New Hampshire
Avenue NW., Washington, DC 20037.
Contact Person: Lilia Topol, Ph.D. Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6192, MSC 7804, Bethesda, MD 20892, 301-451-
0131, ltopol@mail.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel Small Business: Biochemistry, Biophysics, and Drug Discovery.
Date: March 12, 2012.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Doubletree Hotel Bethesda, (Formerly Holiday Inn Select),
8120 Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Sergei Ruvinov, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4158, MSC 7806, Bethesda, MD
20892, 301-435-1180, ruvinser@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel Biological Chemistry and Macromolecular Biophysics B.
Date: March 12-13, 2012.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: William A. Greenberg, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4168, MSC 7806, Bethesda, MD
20892, (301) 435-1726, greenbergwa@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel Epilepsy: Imaging, Surgery and Sleep Disorders.
Date: March 12-13, 2012.
Time: 10 a.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Suzan Nadi, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5217B, MSC 7846, Bethesda, MD 20892, 301-435-
1259, nadis@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel Fellowships: Risk, Health and Healthcare.
Date: March 13-14, 2012.
Time: 8 a.m. to 5 p.m..
Agenda: To review and evaluate grant applications.
Place: Residence Inn Bethesda Downtown, 7335 Wisconsin Avenue,
Bethesda, MD 20814.
Contact Person: Karin F Helmers, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3166, MSC 7770, Bethesda, MD
20892, 301-254-9975, helmersk@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel PAR-09-220 and PAR-09-221: Innovations in Biomedical
Computational Science and Technology Initiative.
Date: March 13, 2012.
Time: 3 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hotel Nikko San Francisco, 222 Mason Street, San
Francisco, CA 94102.
Contact Person: Keith Crutcher, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5207, MSC 7846, Bethesda, MD
20892, 301-435-1278, crutcherka@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
[[Page 8268]]
Dated: February 7, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-3434 Filed 2-13-12; 8:45 am]
BILLING CODE 4140-01-P
